Quantitative Structure-Activity Relationship (QSAR) is the foundational computational chemistry paradigm establishing that the biological activity of a molecule is a quantitative function of its chemical structure — developing mathematical models that map molecular descriptors (structural features, physicochemical properties, topological indices) to biological endpoints (potency, toxicity, selectivity), the intellectual ancestor of modern molecular property prediction and AI-driven drug design.

What Is QSAR?

• Definition: QSAR builds regression or classification models of the form $ ext{Activity} = f( ext{Descriptors})$, where descriptors are numerical features computed from molecular structure — constitutional (atom counts, bond counts), topological (Wiener index, connectivity indices), electronic (partial charges, HOMO energy), physicochemical (LogP, polar surface area, molar refractivity) — and activity is a measured biological endpoint (IC$_{50}$, LD$_{50}$, binding affinity, % inhibition).
• Hansch Equation: The founding equation of QSAR (Hansch & Fujita, 1964): $log(1/C) = a cdot pi + b cdot sigma + c cdot E_s + d$, relating biological potency ($1/C$, where $C$ is concentration for half-maximal effect) to hydrophobicity ($pi$, partition coefficient), electronic effects ($sigma$, Hammett constant), and steric effects ($E_s$). This linear model captured the fundamental principle that activity depends on transport (getting to the target), binding (fitting the active site), and reactivity (chemical mechanism).
• Modern QSAR (DeepQSAR): Classical QSAR used hand-crafted descriptors with linear regression. Modern QSAR (2015+) uses learned representations — molecular fingerprints with random forests, graph neural networks, Transformers on SMILES — that automatically extract relevant features from molecular structure, dramatically improving prediction accuracy on complex biological endpoints.

Why QSAR Matters

• Drug Discovery Foundation: QSAR established the principle that biological activity can be predicted from structure — the foundational assumption underlying all computational drug design. Every virtual screening campaign, every molecular property predictor, and every generative drug design model implicitly relies on the QSAR hypothesis that structure determines function.
• Regulatory Acceptance: QSAR models are formally accepted by regulatory agencies (FDA, EMA, REACH) for toxicity prediction and safety assessment of chemicals when experimental data is unavailable. The OECD guidelines for QSAR validation (defined applicability domain, statistical performance, mechanistic interpretation) established the standards for computational predictions in regulatory decision-making.
• Lead Optimization: Medicinal chemists use QSAR models to guide Structure-Activity Relationship (SAR) studies — predicting which structural modifications will improve potency, selectivity, or ADMET properties before synthesizing the molecule. A QSAR model predicting that adding a methyl group at position 4 increases binding by 10-fold saves weeks of trial-and-error synthesis.
• ADMET Prediction: The most widely deployed QSAR models predict ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) properties — Lipinski's Rule of 5 (oral bioavailability), hERG channel inhibition (cardiac toxicity risk), CYP450 inhibition (drug-drug interactions), and Ames mutagenicity (carcinogenicity risk). These models filter drug candidates before expensive in vivo testing.

QSAR Evolution

QSAR is the structure-activity hypothesis — the foundational principle that a molecule's shape and properties mathematically determine its biological behavior, underpinning sixty years of computational drug design from linear regression on hand-crafted descriptors to modern graph neural networks learning directly from molecular structure.